|
Matthew J. Gardella
617 348 1745
mgardella@mintz.com
|
 |
One Financial Center
Boston, MA 02111
617 542 6000
mintz.com
|
May 10, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Re: Standard BioTools Inc. – Preliminary Proxy Statement (PREC14A)
Ladies and Gentlemen:
On behalf of our client, Standard BioTools Inc., we hereby submit for filing by direct electronic transmission under the Exchange
Act of 1934, as amended, a preliminary proxy statement. If you have any questions regarding the filing, please contact the undersigned at (617) 348-1735. Thank you.
|
Very truly yours,
|
|
|
/s/ Matthew J. Gardella
|
|
|
Matthew J. Gardella
Member
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
|